Alliance Pharma's Recent Trading Disclosure Insights
Recent Trading Disclosure by Alliance Pharma plc
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code
Key Information
(a) Name of exempt principal trader: Investec Bank plc
(b) Name of offeror/offeree: Alliance Pharma plc
(c) Name of the party connected: Investec is the financial advisor to Aegros Bidco Limited, a company associated with DBAY Affiliates and the ERES IV Fund.
(d) Date of dealing undertaken: January 27, 2025
(e) Is the exempt principal trader making disclosures regarding any other party to this offer?
N/A
Dealings by the Exempt Principal Trader
Note: Where there have been dealings in more than one class of relevant securities, separate tables may be provided.
Purchases and SalesClass of relevant security: Ordinary shares
Type of transaction: Sales
Total number of securities: 252,225
Highest price per unit: 61.25
Lowest price per unit: 61.2
Cash-Settled Derivative Transactions
Class of relevant security: N/A
Product Description: N/A
Nature of dealing: N/A
Number of reference securities: N/A
Price per unit: N/A
Stock-Settled Derivative Transactions
Writing, Selling, Purchasing or Varying
Class of relevant security: N/A
Product Description: N/A
Nature of dealing: N/A
Number of securities: N/A
Exercise price per unit: N/A
Exercise Information
Class of relevant security: N/A
Product description: N/A
Number of securities: N/A
Exercise price per unit: N/A
Other Dealings
Class of relevant security: N/A
Nature of dealing: N/A
Price per unit: N/A
Additional Information
Indemnity and Other Dealing ArrangementsDetails: None
Agreements Related to Options or DerivativesDetails: None
Date of disclosure: January 28, 2025
Contact name: Abhishek Gawde
Telephone number: +91 9923757332
Frequently Asked Questions
1. What is the purpose of this Form 8.5 disclosure?
The Form 8.5 disclosure provides essential information about the trading activities of an exempt principal trader, ensuring transparency in market dealings.
2. Who is Investec Bank plc in connection with this disclosure?
Investec Bank plc serves as the exempt principal trader and is also the financial advisor guiding Aegros Bidco Limited in this transaction.
3. How many ordinary shares were sold according to the disclosure?
A total of 252,225 ordinary shares were sold as per the trading disclosure.
4. What was the highest price per unit for the shares sold?
The highest price per unit for the ordinary shares sold was 61.25.
5. How can I contact the disclosed contact person for further information?
You can contact Abhishek Gawde at +91 9923757332 for any inquiries related to the disclosure.
About The Author
Contact Riley Hayes here.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.